(Q36410788)

14 August 2017

1 reference

title

A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers (English)

1 reference

14 August 2017

Dumont GJ

1

1 reference

PubMed ID

16510476

14 August 2017

Verkes RJ

series ordinal

2

1 reference

PubMed ID

16510476

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Journal of Psychopharmacology

14 August 2017

1 reference

14 August 2017

20

1 reference

14 August 2017

2

1 reference

14 August 2017

176-187

1 reference

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

14 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Is MDMA ('Ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Pharmacology of MDMA in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Biomarkers for the effects of antipsychotic drugs in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Biomarkers for the effects of benzodiazepines in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine ("ecstasy"): is metabolism a contributory factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Ecstasy and drug consumption patterns: a Canadian rave population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Brain concentrations of d-MDMA are increased after stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Serotonergic neurotoxic metabolites of ecstasy identified in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Endogenous 5‐HT, released by MDMA through serotonin transporter‐ and secretory vesicle‐dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5‐HT1B receptors located on CA1 pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Structure-activity relationships of MDMA and related compounds: a new class of psychoactive drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Immunomodulating activity of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Hyperkalemia in fatal MDMA ('ecstasy') toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Persistent neuropsychological problems after 7 years of abstinence from recreational Ecstasy (MDMA): a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

The subjective effects of MDMA and mCPP in moderate MDMA users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Specific memory deficits in ecstasy users? The results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Acute Psychological and Neurophysiological Effects of MDMA in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106063271

21 January 2018

Identifiers

DOI

10.1177/0269881106063271

1 reference

14 August 2017

1 reference

PubMed ID

16510476